Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Marschner

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
BMC Medical Research Methodology|April 2, 2010
Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID studyJisheng Cui, Andrew Forbes, Adrienne Kirby, et al.
Future Oncology (London, England)|February 18, 2026
Time to achieve response and depth of maximal tumor response as potential surrogates for overall survival in advanced non-small cell lung cancerRachel Woodford, Sally Lord, Tom John, et al.
American Heart Journal|October 23, 2023
A randomized trial of expedited intra-arrest transfer versus more extended on-scene resuscitation for refractory out of hospital cardiac arrest: Rationale and design of the EVIDENCE trialBrian Burns, Ian Marschner, Renee Eggins, et al.
European Heart Journal|May 4, 2004
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID studyDavid Colquhoun, Anthony Keech, David Hunt, et al.
Pancreas|November 6, 2019
Evaluation of Phase II Trial Design in Advanced Pancreatic CancerMonica Tang, Julia Chen, David Goldstein, et al.
Spine|September 11, 2002
A randomized controlled trial of exercise and manipulative therapy for cervicogenic headacheGwendolen Jull, Patricia Trott, Helen Potter, et al.
The Medical Journal of Australia|December 2, 2006
Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic reviewDelia Schaffer, Timothy Florin, Craig Eagle, et al.
JCO Precision Oncology|January 11, 2024
Validity and Efficiency of Progression-Free Survival-2 as a Surrogate End Point for Overall Survival in Advanced Cancer Randomized TrialsRachel Woodford, Deborah Zhou, Peey-Sei Kok, et al.
JAMA Network Open|September 8, 2020
Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-analysisPeey-Sei Kok, Doah Cho, Won-Hee Yoon, et al.
Lung Cancer (Amsterdam, Netherlands)|December 11, 2021
Incorporating circulating tumor DNA detection to radiographic assessment for treatment response in advanced EGFR-mutant lung cancerPeey-Sei Kok, Kirsty Lee, Sally Lord, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
BMC Medical Research Methodology|April 2, 2010
Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID studyJisheng Cui, Andrew Forbes, Adrienne Kirby, et al.
Future Oncology (London, England)|February 18, 2026
Time to achieve response and depth of maximal tumor response as potential surrogates for overall survival in advanced non-small cell lung cancerRachel Woodford, Sally Lord, Tom John, et al.
American Heart Journal|October 23, 2023
A randomized trial of expedited intra-arrest transfer versus more extended on-scene resuscitation for refractory out of hospital cardiac arrest: Rationale and design of the EVIDENCE trialBrian Burns, Ian Marschner, Renee Eggins, et al.
European Heart Journal|May 4, 2004
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID studyDavid Colquhoun, Anthony Keech, David Hunt, et al.
Pancreas|November 6, 2019
Evaluation of Phase II Trial Design in Advanced Pancreatic CancerMonica Tang, Julia Chen, David Goldstein, et al.
Spine|September 11, 2002
A randomized controlled trial of exercise and manipulative therapy for cervicogenic headacheGwendolen Jull, Patricia Trott, Helen Potter, et al.
The Medical Journal of Australia|December 2, 2006
Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic reviewDelia Schaffer, Timothy Florin, Craig Eagle, et al.
JCO Precision Oncology|January 11, 2024
Validity and Efficiency of Progression-Free Survival-2 as a Surrogate End Point for Overall Survival in Advanced Cancer Randomized TrialsRachel Woodford, Deborah Zhou, Peey-Sei Kok, et al.
JAMA Network Open|September 8, 2020
Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-analysisPeey-Sei Kok, Doah Cho, Won-Hee Yoon, et al.
Lung Cancer (Amsterdam, Netherlands)|December 11, 2021
Incorporating circulating tumor DNA detection to radiographic assessment for treatment response in advanced EGFR-mutant lung cancerPeey-Sei Kok, Kirsty Lee, Sally Lord, et al.
Pageof 4